Tower Research Capital LLC (Trc) Ocular Therapeutix, Inc Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,682 shares of OCUL stock, worth $11,504. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,682

Previous 9,756 82.76%

Holding current value

$11,504

Previous $43,000 65.12%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.85 - $10.93 $31,084 - $88,248	-8,074 Reduced 82.76%	1,682 $15,000
Q4 2023 Feb 13, 2024	BUY	$2.08 - $4.52 $11,918 - $25,899	5,730 Added 142.32%	9,756 $43,000
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $5,231 - $8,396	1,666 Added 70.59%	4,026 $12,000
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $763 - $1,268	-166 Reduced 6.57%	2,360 $12,000
Q1 2023 May 09, 2023	SELL	$2.79 - $6.27 $39,503 - $88,776	-14,159 Reduced 84.86%	2,526 $13,000

Q4 2022 Feb 10, 2023	BUY	$2.61 - $4.41 $25,035 - $42,300	9,592 Added 135.23%	16,685 $47,000
Q3 2022 Nov 10, 2022	BUY	$4.09 - $6.5 $5,897 - $9,373	1,442 Added 25.52%	7,093 $29,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $12,726 - $22,070	4,228 Added 297.12%	5,651 $23,000
Q1 2022 May 12, 2022	SELL	$4.83 - $7.35 $6,902 - $10,503	-1,429 Reduced 50.11%	1,423 $7,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $9,985 - $19,565	-1,621 Reduced 36.24%	2,852 $20,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $36,947 - $54,621	-3,809 Reduced 45.99%	4,473 $44,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $54,136 - $77,233	4,031 Added 94.82%	8,282 $118,000
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $5,552 - $7,760	-351 Reduced 7.63%	4,251 $70,000
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $416,754 - $1.21 Million	-52,687 Reduced 91.97%	4,602 $95,000
Q3 2020 Nov 16, 2020	BUY	$7.36 - $9.87 $350,446 - $469,960	47,615 Added 492.2%	57,289 $436,000
Q2 2020 Aug 13, 2020	BUY	$4.67 - $8.95 $35,407 - $67,858	7,582 Added 362.43%	9,674 $81,000
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $8,263 - $15,480	2,092 New	2,092 $10,000
Q4 2019 Feb 07, 2020	SELL	$2.57 - $4.73 $1,858 - $3,419	-723 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$3.04 - $5.32 $3,641 - $6,373	-1,198 Reduced 62.36%	723 $2,000
Q2 2019 Aug 13, 2019	SELL	$2.46 - $4.52 $29,980 - $55,085	-12,187 Reduced 86.38%	1,921 $8,000
Q1 2019 May 14, 2019	BUY	$3.51 - $4.77 $16,135 - $21,927	4,597 Added 48.33%	14,108 $56,000
Q4 2018 Feb 14, 2019	BUY	$3.87 - $7.11 $34,516 - $63,414	8,919 Added 1506.59%	9,511 $38,000
Q3 2018 Nov 13, 2018	SELL	$5.42 - $6.99 $12,178 - $15,706	-2,247 Reduced 79.15%	592 $4,000
Q2 2018 Aug 15, 2018	BUY	$5.99 - $8.17 $13,549 - $18,480	2,262 Added 392.03%	2,839 $19,000
Q1 2018 May 15, 2018	SELL	$4.66 - $7.08 $28,626 - $43,492	-6,143 Reduced 91.41%	577 $4,000
Q4 2017 Feb 09, 2018	BUY	$3.73 - $6.37 $5,389 - $9,204	1,445 Added 27.39%	6,720 $30,000
Q3 2017 Nov 14, 2017	BUY	$5.28 - $6.88 $27,852 - $36,292	5,275	5,275 $33,000

Others Institutions Holding OCUL

# of Institutions

148

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Ocular Therapeutix, Inc Transaction History